Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

106.10
-0.5200-0.49%
Volume:196.05K
Turnover:20.77M
Market Cap:5.93B
PE:-25.80
High:110.44
Open:107.69
Low:103.28
Close:106.62
52wk High:117.88
52wk Low:23.39
Shares:55.93M
Float Shares:55.85M
Volume Ratio:0.60
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:5.06
PE(LYR):-25.24

Loading ...

May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Major Issues Report

Form 8-K - Current report
Apr 27, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2026

Major Issues Report

Form 8-K - Current report
Mar 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2026

Major Issues Report

Form 8-K - Current report
Mar 09, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 30, 2026

Correspondence

Form CORRESP - Correspondence